What Patients Need to Know About Lung Cancer Immunotherapy August 14, 2015December 14, 2022 Michelle Liew
CRI Awards $29.3 Million to Fund Immunotherapies for All Kinds of Cancer August 6, 2015December 14, 2022 Alexandra Mulvey
European Regulators Approve Pembrolizumab (Keytruda) as First-line Treatment of Advanced Melanoma July 22, 2015December 14, 2022 Matthew Tontonoz
Phase 3 Trial Shows Nivolumab Improves Survival in Advanced Kidney Cancer July 20, 2015December 14, 2022 Matthew Tontonoz
A Cross-Country Biking Trip to Raise Awareness and Funding for Cancer Immunotherapy Research July 15, 2015December 14, 2022 CRI Staff